2 results
Approved WMOCompleted
To investigate whether statin treatment can prevent or delay the development of RA in persons at increased risk of RA.
Approved WMOCompleted
Primary Objectivea) Phase I (Safety Run-in) The primary objective of the Phase I Safety Run-in part is to investigate the safety of IO102 in combination with either pembrolizumab alone or pembrolizumab and chemotherapy (carboplatin and pemetrexed)…